You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》思派健康通過上市聆訊 騰訊(00700.HK)持股27.7%
阿思達克 12-05 14:11
思派健康近日通過聯交所上市聆訊,由摩根士丹利和海通國際擔任聯席保薦人。 聆訊後招股資料顯示,思派健康主要從事特藥藥房業務、醫生研究協助業務及健康保險服務,並圍繞合作夥伴及三條業務線建立自我強化的生態系統,截至今年6月底止健康保險服務已連接中國150多個主要城市的醫院、全科醫生及專家的健康服務提供商網絡,服務約2,390萬名健康保險計劃會員。 今年上半年思派健康錄得收入18.87億元人民幣,按年增長21.8%,中期虧損則收窄至3.46億元,對比2021年上半年蝕25.1億元人民幣。 該公司自2015年起進行多輪融資,引入Eight Roads Capital、F-Prime Capital、騰訊(00700.HK)、IDG等投資者,於上市前騰訊集團實體共持有思派健康27.7%股權,為最大機構股東,而其他上市前投資者則合共持有約30.38%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account